What is Methylmalonic acidemia

Methylmalonic acidemia (MMA) is a rare, life-threatening genetic metabolic disorder that prevents the body from properly processing certain proteins and fats, leading to a toxic buildup of methylmalonic acid in the blood and tissues. Without careful management, this accumulation can cause serious health complications, including metabolic crises, developmental delays, and organ damage.

What is the underlying cause of Methylmalonic acidemia?

Methylmalonic acidemia is caused by a deficiency in an enzyme (most commonly methylmalonyl-CoA mutase) or a defect in the metabolism of vitamin B12 (cobalamin). These components are essential for breaking down specific amino acids, odd-chain fatty acids, and cholesterol. When this process fails, methylmalonic acid and other toxic byproducts accumulate. This chemical imbalance disrupts cellular function, particularly in the brain, kidneys, and liver, which are the systems most frequently impacted by Methylmalonic acidemia.

How does Methylmalonic acidemia affect the body?

The impact of Methylmalonic acidemia varies significantly depending on the specific genetic subtype and the severity of enzyme deficiency. Symptoms can range from mild to severe and often involve multiple body systems:

• Metabolic crises: Sudden episodes of vomiting, lethargy, dehydration, and potentially coma, often triggered by illness or high protein intake.


• Neurological impact: Developmental delays, intellectual disability, seizures, and movement disorders.


• Organ damage: Chronic kidney disease and liver enlargement (hepatomegaly).


• Hematological issues: Anemia, neutropenia (low white blood cell count), and thrombocytopenia (low platelet count).

How common is Methylmalonic acidemia and who does it affect?

Methylmalonic acidemia is considered a rare disease, with an estimated global incidence ranging from 1 in 50,000 to 1 in 100,000 live births, though rates can be higher in populations with high rates of consanguinity. It affects males and females equally and is typically diagnosed in infancy, often through newborn screening programs. While symptoms usually present in the first few weeks of life, some milder forms of Methylmalonic acidemia may not manifest until childhood or early adulthood.

How is Methylmalonic acidemia different from other metabolic disorders?

While Methylmalonic acidemia shares features with other organic acidemias, it is distinguished by the specific accumulation of methylmalonic acid in urine and blood. Key differentiators include:

1. Vitamin B12 responsiveness: Some forms of Methylmalonic acidemia are "B12-responsive," meaning patients show significant clinical improvement when treated with high doses of Vitamin B12, unlike other metabolic disorders that do not respond to vitamin supplementation.


2. Genetic complexity: It can be caused by mutations in the MUT gene or several different genes involved in the cobalamin (B12) pathway (such as MMAA, MMAB, or MMACHC).


3. Long-term management: Unlike many conditions, successful management relies heavily on a specialized low-protein diet combined with carnitine supplementation to help the body excrete toxic metabolites.

Next steps

• Consult with a metabolic specialist or a geneticist to confirm a diagnosis and discuss personalized management plans.


• Connect with the 54 members of the DiseaseMaps.org community who are living with Methylmalonic acidemia to share experiences and find emotional support.


• Work with a metabolic dietitian to create a strictly monitored, age-appropriate low-protein diet.


• Register with a patient advocacy organization, such as the Organic Acidemia Association, for the latest research and clinical trial information.

Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Methylmalonic acidemia.


• Orphanet: Methylmalonic acidemia (ORPHA:576).


• OMIM (Online Mendelian Inheritance in Man): Entry #251000.


• Organic Acidemia Association (OAA) patient resources.